What is Cetrorelix Acetate?

Cetrorelix Acetate (CAS Number: 120287-85-6) is a synthetic decapeptide and a potent GnRH antagonist. It is widely used in assisted reproductive technology (ART), including IVF, to prevent premature ovulation during ovarian stimulation cycles. By blocking GnRH receptors, Cetrorelix suppresses LH and FSH release, enabling precise control over follicular development and improving ART success rates.

Standard: In-House / IP / EP / BP. Hennan Medscience Pharmaceuticals supplies high-purity, GMP-compliant Cetrorelix Acetate API suitable for formulation development and global commercial use.

Applications of Cetrorelix Acetate

• 1. In Vitro Fertilization (IVF): Prevents premature LH surges, ensuring synchronization between follicle development and egg retrieval for improved fertilization and embryo quality.
• 2. Controlled Ovarian Stimulation (COS): Provides clinicians precise control over ovulation when combined with gonadotropins (FSH, hCG), enhancing cycle flexibility and pregnancy success rates.
• 3. Endometriosis Management: Suppresses ovarian hormone production, reducing estrogen levels, pelvic pain, and menstrual irregularities for better reproductive health management.
• 4. Research & Development: Serves as a valuable tool in reproductive endocrinology to study GnRH receptor biology, ovarian function, and infertility mechanisms.

Key Benefits of Cetrorelix Acetate

• Precise hormonal control in ART cycles
• Prevents premature ovulation for optimized IVF outcomes
• Improves embryo quality and fertilization rates
• Applicable in endometriosis and other hormone-dependent conditions
• High-purity, GMP-compliant API for pharmaceutical development

Safety & Clinical Guidance

Cetrorelix Acetate should be administered under professional medical supervision. Patients are closely monitored during ART cycles to ensure safety, efficacy, and optimal reproductive outcomes. Possible side effects may include injection site reactions, headache, or temporary hormonal fluctuations.